FREMGANGSMAADE TIL FREMSTILLING AF SUBSTITUEREDE PYRIMID-2-ONER ELLER SALTE DERAF

Compounds of general formula: (I) (wherein X represents a halogen atom or a trifluoromethyl group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a C1-4 alkyl group, and R3 represents a hydrogen atom or a C1-5 saturated or unsaturated, straight or branched acyclic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GACEK MIKKEL JOSEF, UNDHEIM KJELL, BENNECHE TORE
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GACEK MIKKEL JOSEF
UNDHEIM KJELL
BENNECHE TORE
description Compounds of general formula: (I) (wherein X represents a halogen atom or a trifluoromethyl group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a C1-4 alkyl group, and R3 represents a hydrogen atom or a C1-5 saturated or unsaturated, straight or branched acyclic aliphatic group; a C3-8 saturated or unsaturated cyclic aliphatic group; a heterocyclic substituted aliphatic group; an araliphatic group; or a heterocyclic or carbocyclic aryl group; any of said groups optionally carrying one or more substituents selected from halogen, oxo, hydroxy, mercapto, C1-4 alkyl, C1-4 alkoxy, C1-4 alkanoyloxy and amino) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds of formula I may be prepared by reaction of a 5-halo- or 5-trifluoromethyl-pyrimidin-2-one with an appropriate isocyanate.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK404982A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK404982A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK404982A3</originalsourceid><addsrcrecordid>eNrjZAh0C3L1dXf0cw_2dXR0cVUI8fRRAAkFAxk-nn7uCo5uCsGhTkBuSKhrkCtQRUBkkKevp4uuka6_n2uQgquPD5AMdvQJcVVwcQ1ydONhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfEu3iYGJpYWRo7GBBUAAJQrLgs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FREMGANGSMAADE TIL FREMSTILLING AF SUBSTITUEREDE PYRIMID-2-ONER ELLER SALTE DERAF</title><source>esp@cenet</source><creator>GACEK MIKKEL JOSEF ; UNDHEIM KJELL ; BENNECHE TORE</creator><creatorcontrib>GACEK MIKKEL JOSEF ; UNDHEIM KJELL ; BENNECHE TORE</creatorcontrib><description>Compounds of general formula: (I) (wherein X represents a halogen atom or a trifluoromethyl group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a C1-4 alkyl group, and R3 represents a hydrogen atom or a C1-5 saturated or unsaturated, straight or branched acyclic aliphatic group; a C3-8 saturated or unsaturated cyclic aliphatic group; a heterocyclic substituted aliphatic group; an araliphatic group; or a heterocyclic or carbocyclic aryl group; any of said groups optionally carrying one or more substituents selected from halogen, oxo, hydroxy, mercapto, C1-4 alkyl, C1-4 alkoxy, C1-4 alkanoyloxy and amino) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds of formula I may be prepared by reaction of a 5-halo- or 5-trifluoromethyl-pyrimidin-2-one with an appropriate isocyanate.</description><edition>3</edition><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1983</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19830312&amp;DB=EPODOC&amp;CC=DK&amp;NR=404982A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19830312&amp;DB=EPODOC&amp;CC=DK&amp;NR=404982A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GACEK MIKKEL JOSEF</creatorcontrib><creatorcontrib>UNDHEIM KJELL</creatorcontrib><creatorcontrib>BENNECHE TORE</creatorcontrib><title>FREMGANGSMAADE TIL FREMSTILLING AF SUBSTITUEREDE PYRIMID-2-ONER ELLER SALTE DERAF</title><description>Compounds of general formula: (I) (wherein X represents a halogen atom or a trifluoromethyl group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a C1-4 alkyl group, and R3 represents a hydrogen atom or a C1-5 saturated or unsaturated, straight or branched acyclic aliphatic group; a C3-8 saturated or unsaturated cyclic aliphatic group; a heterocyclic substituted aliphatic group; an araliphatic group; or a heterocyclic or carbocyclic aryl group; any of said groups optionally carrying one or more substituents selected from halogen, oxo, hydroxy, mercapto, C1-4 alkyl, C1-4 alkoxy, C1-4 alkanoyloxy and amino) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds of formula I may be prepared by reaction of a 5-halo- or 5-trifluoromethyl-pyrimidin-2-one with an appropriate isocyanate.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1983</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAh0C3L1dXf0cw_2dXR0cVUI8fRRAAkFAxk-nn7uCo5uCsGhTkBuSKhrkCtQRUBkkKevp4uuka6_n2uQgquPD5AMdvQJcVVwcQ1ydONhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfEu3iYGJpYWRo7GBBUAAJQrLgs</recordid><startdate>19830312</startdate><enddate>19830312</enddate><creator>GACEK MIKKEL JOSEF</creator><creator>UNDHEIM KJELL</creator><creator>BENNECHE TORE</creator><scope>EVB</scope></search><sort><creationdate>19830312</creationdate><title>FREMGANGSMAADE TIL FREMSTILLING AF SUBSTITUEREDE PYRIMID-2-ONER ELLER SALTE DERAF</title><author>GACEK MIKKEL JOSEF ; UNDHEIM KJELL ; BENNECHE TORE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK404982A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>1983</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GACEK MIKKEL JOSEF</creatorcontrib><creatorcontrib>UNDHEIM KJELL</creatorcontrib><creatorcontrib>BENNECHE TORE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GACEK MIKKEL JOSEF</au><au>UNDHEIM KJELL</au><au>BENNECHE TORE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FREMGANGSMAADE TIL FREMSTILLING AF SUBSTITUEREDE PYRIMID-2-ONER ELLER SALTE DERAF</title><date>1983-03-12</date><risdate>1983</risdate><abstract>Compounds of general formula: (I) (wherein X represents a halogen atom or a trifluoromethyl group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a C1-4 alkyl group, and R3 represents a hydrogen atom or a C1-5 saturated or unsaturated, straight or branched acyclic aliphatic group; a C3-8 saturated or unsaturated cyclic aliphatic group; a heterocyclic substituted aliphatic group; an araliphatic group; or a heterocyclic or carbocyclic aryl group; any of said groups optionally carrying one or more substituents selected from halogen, oxo, hydroxy, mercapto, C1-4 alkyl, C1-4 alkoxy, C1-4 alkanoyloxy and amino) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds of formula I may be prepared by reaction of a 5-halo- or 5-trifluoromethyl-pyrimidin-2-one with an appropriate isocyanate.</abstract><edition>3</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK404982A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FREMGANGSMAADE TIL FREMSTILLING AF SUBSTITUEREDE PYRIMID-2-ONER ELLER SALTE DERAF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T08%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GACEK%20MIKKEL%20JOSEF&rft.date=1983-03-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK404982A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true